Jeffrey V. Poulton
2020
Compensation breakdown
| Non-Equity Incentive Plan | $322,560 |
|---|---|
| Option Awards | $1,598,986 |
| Salary | $556,800 |
| Other | $14,113 |
| Total | $2,492,459 |
Poulton received $1.6M in option awards, accounting for 64% of the total pay in 2020.
Poulton also received $322.6K in non-equity incentive plan, $556.8K in salary and $14.1K in other compensation.
Rankings
In 2020, Jeffrey V. Poulton's compensation ranked 4,565th out of 13,090 executives tracked by ExecPay. In other words, Poulton earned more than 65.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,565 out of 13,090 | 65th |
Division Manufacturing | 1,847 out of 5,620 | 67th |
Major group Chemicals And Allied Products | 719 out of 2,253 | 68th |
Industry group Drugs | 616 out of 1,953 | 69th |
Industry Pharmaceutical Preparations | 466 out of 1,458 | 68th |
Pay ratio
| Jeffrey V. Poulton's Pay | $2,492,459 |
|---|---|
| Median Employee's Pay | $233,341 |
| Pay Ratio | 11to 1 |
In 2020, the annual total compensation of Jeffrey V. Poulton was $2,492,459.
The annual total compensation of the median employee at Alnylam Pharmaceuticals was $233,341.
The ratio of Jeffrey V. Poulton's pay to the pay of median employee was therefore 11 to one.
Poulton's colleagues
We found five more compensation records of executives who worked with Jeffrey V. Poulton at Alnylam Pharmaceuticals in 2020.
2020
Barry Greene
Alnylam Pharmaceuticals
Former President
2020
John Maraganore
Alnylam Pharmaceuticals
Chief Executive Officer
2020
Yvonne Greenstreet
Alnylam Pharmaceuticals
Chief Operating Officer
2020
Akshay Vaishnaw
Alnylam Pharmaceuticals
President, Research and Development
2020
Laurie Keating
Alnylam Pharmaceuticals